KLP Kapitalforvaltning’s Adaptive Biotechnologies ADPT Stock Holding History

KLP Kapitalforvaltning’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$536K	Hold	25,000	–	–	﹤0.01%	1477
2026 Q1	$347K	Hold	25,000	–	–	﹤0.01%	1593
2025 Q4	$406K	Hold	25,000	–	–	﹤0.01%	1514
2025 Q3	$374K	Hold	25,000	–	–	﹤0.01%	1546
2025 Q2	$291K	Buy	25,000 +7,500	+43%	+$68.1K	﹤0.01%	1611
2025 Q1	$130K	Sell	17,500 -8,300	-32%	-$63.8K	﹤0.01%	1923
2024 Q4	$155K	Buy	+25,800	New	+$142K	﹤0.01%	1926

Other funds holding ADPT

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

KLP Kapitalforvaltning's ADPT Position: Q2 2026 in Review

KLP Kapitalforvaltning held its Adaptive Biotechnologies (ADPT) position steady in Q2 2026 at 25,000 shares worth $536K. The position accounts for ﹤0.01% of the portfolio, ranked #1477.

KLP Kapitalforvaltning first reported a position in ADPT in Q4 2024 and has held it in 7 quarters since. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

KLP Kapitalforvaltning held 25,000 shares of Adaptive Biotechnologies worth $536K as of Q2 2026.
KLP Kapitalforvaltning left its Adaptive Biotechnologies share count unchanged in Q2 2026.
Adaptive Biotechnologies made up ﹤0.01% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #1477 holding.
KLP Kapitalforvaltning first reported a position in Adaptive Biotechnologies in Q4 2024 and has held it in 7 quarters since.
301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.